Biodegradation of porous calcium phosphate scaffolds in an ectopic bone formation model studied by X-ray computed microtomograph.
Three types of ceramic scaffolds with different composition and structure [namely synthetic 100% hydroxyapatite (HA; Engipore), synthetic calcium phosphate multiphase biomaterial containing 67% silicon stabilized tricalcium phosphate (Si-TCP; Skelite) and natural bone mineral derived scaffolds (Bio-oss)] were seeded with mesenchymal stem cells (MSC) and ectopically implanted for 8 and 16 weeks in immunodeficient mice. X-ray synchrotron radiation microtomography was used to derive 3D structural information on the same scaffolds both before and after implantation. Meaningful images and morphometric parameters such as scaffold and bone volume fraction, mean thickness and thickness distribution of the different phases as a function of the implantation time, were obtained. The used imaging algorithms allowed a direct comparison and registration of the 3D structure before and after implantation of the same sub-volume of a given scaffold. In this way it was possible to directly monitor the tissue engineered bone growth and the complete or partial degradation of the scaffold. Further, the detailed kinetics studies on Skelite scaffolds implanted for different length of times from 3 days to 24 weeks, revealed in the X-ray absorption histograms two separate peaks associated to HA and TCP. It was therefore possible to observe that the progressive degradation of the Skelite scaffolds was mainly due to the resorption of TCP. The different saturation times in the tissue engineered bone growth and in the TCP resorption confirmed that the bone growth was not limited the scaffold regions that were resorbed but continued in the inward direction with respect to the pore surface.
Komlev
V S
VS
Istituto Nazionale per la Ricerca sul Cancro and Dipartimento di Oncologia, Biologia e Genetica dell'Universita' di Genova, Genova, Italy.
Mastrogiacomo
M
M
Pereira
R C
RC
Peyrin
F
F
Rustichelli
F
F
Cancedda
R
R
D020341:Absorbable Implants / Q000592:standards*; D000465:Algorithms; D000818:Animals; D001842:Bone and Bones / Q000000981:diagnostic imaging / Q000378:metabolism; D002130:Calcium Phosphates / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use; D002516:Ceramics / Q000378:metabolism* / Q000493:pharmacokinetics / Q000627:therapeutic use; D002828:Choristoma / Q000000981:diagnostic imaging / Q000378:metabolism; D004195:Disease Models, Animal; D007091:Image Processing, Computer-Assisted / Q000379:methods; D021621:Imaging, Three-Dimensional / Q000379:methods; D007700:Kinetics; D008422:Materials Testing / Q000379:methods*; D045164:Mesenchymal Stem Cell Transplantation / Q000379:methods; D051379:Mice; D010012:Osteogenesis / Q000502:physiology; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds / Q000592:standards*; D055114:X-Ray Microtomography / Q000379:methods*
D002130:Calcium Phosphates; C020243:calcium phosphate